FDA Drug Application (202236) for DYMISTA by MEDA PHARMS

Back to FDA Applications sponsored by MEDA PHARMS

Application Number202236
Product Number001
FormSPRAY, METERED;NASAL
DosageEQ 0.125MG BASE/SPRAY;0.05MG/SPRAY
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDYMISTA
Active IngredientAZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Active IngredientCount
List of drugs with Active Ingredient AZELASTINE HYDROCHLORIDE5
List of drugs with Active Ingredient FLUTICASONE PROPIONATE14


Back to FDA Applications sponsored by MEDA PHARMS